RAPT Therapeutics Ownership | Who Owns RAPT Therapeutics?

Overview Forecast RevenueFinancials Chart

RAPT Therapeutics Ownership Summary

RAPT Therapeutics is owned by 82.35% institutional investors, 1.84% insiders, and 15.81% retail investors. Fmr is the largest institutional shareholder, holding 13.55% of RAPT shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.77% of its assets in RAPT Therapeutics shares.

RAPT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	RAPT Therapeutics	82.35%	1.84%	15.81%
Sector	Healthcare Stocks	46.98%	7.90%	45.12%
Industry	Biotech Stocks	44.85%	7.67%	47.48%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	5.24M	13.55%	$15.97M
Vanguard group	3.11M	8.05%	$9.48M
Column group	2.68M	6.94%	$8.18M
Blackrock	2.44M	6.32%	$7.44M
Kingdon capital management	1.73M	4.47%	$5.26M
Morgan stanley	1.18M	3.05%	$3.60M
Deutsche bank ag\	932.54K	2.41%	$2.84M
D. e. shaw	907.41K	2.35%	$2.77M
Federated hermes	796.08K	2.06%	$2.43M
Point72 asset management	707.30K	1.83%	$2.16M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Column group	2.68M	11.47%	$8.18M
Kingdon capital management	1.73M	0.56%	$5.26M
Ghost tree capital	300.00K	0.29%	$915.00K
Sio capital management	315.00K	0.26%	$960.75K
Euclidean capital	657.90K	0.25%	$2.01M
Altium capital management lp	200.00K	0.25%	$610.00K
Ardsley advisory partners lp	500.00K	0.22%	$1.52M
Octagon capital advisors lp	292.00K	0.14%	$890.60K
Redmile group	536.68K	0.10%	$1.64M
Cormorant asset management, lp	496.75K	0.09%	$1.52M

Top Buyers

Holder	Shares	% Assets	Change
Point72 asset management	707.30K	0.01%	706.90K
Deutsche bank ag\	932.54K	0.00%	643.03K
D. e. shaw	907.41K	0.00%	637.27K
Vanguard group	3.11M	0.00%	615.42K
Federated hermes	796.08K	0.01%	520.37K

Top Sellers

Holder	Shares	% Assets	Change
Price t rowe associates inc /md/	208.50K	0.00%	-1.82M
Perceptive advisors	-	-	-1.22M
Morgan stanley	1.18M	0.00%	-726.44K
Ally bridge group (ny)	-	-	-420.00K
Candriam s.c.a.	-	-	-313.26K

New Positions

Holder	Shares	% Assets	Change	Value
Altium capital management lp	200.00K	0.25%	200.00K	$610.00K
Squarepoint ops	107.99K	0.00%	107.99K	$329.38K
Norges bank	100.30K	-	100.30K	$305.92K
Pdt partners	97.81K	0.03%	97.81K	$298.31K
Aqr capital management	88.37K	0.00%	88.37K	$269.54K

Sold Out

Holder	Change
Farther finance advisors	-2.00
Nelson, van denburg & campbell wealth management group	-7.00
Gamma investing	-27.00
Daiwa securities group	-101.00
Comerica bank	-222.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	116	-17.14%	31,809,166	-0.17%	82	1.20%	56	-25.33%	33	10.00%
Mar 31, 2024	140	19.66%	31,861,728	-8.92%	83	1.00%	75	19.05%	30	-14.29%
Dec 31, 2023	117	15.84%	34,982,126	0.63%	91	1.11%	63	50.00%	35	-7.89%
Sep 30, 2023	101	1.00%	34,763,427	2.09%	90	1.15%	42	-12.50%	38	15.15%
Jun 30, 2023	100	-9.09%	34,050,266	2.26%	88	1.18%	48	-18.64%	33	10.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	2.01M	5.77%	11.83K
Fidelity Growth Compy Commingled Pl O	2.00M	5.73%	-
Fidelity Growth Company Fund	1.52M	4.34%	-3.22K
Vanguard Total Stock Mkt Idx Inv	1.12M	3.22%	-
Fidelity Select Biotechnology	802.70K	2.30%	-
iShares Russell 2000 ETF	730.79K	2.09%	-1.64K
Fidelity Growth Company K6	499.30K	1.43%	-8.62K
Federated Hermes MDT Small Cap Core IS	461.23K	1.32%	-
Federated Hermes MDT SCC Institutional	461.23K	1.32%	-
Vanguard Institutional Extnd Mkt Idx Tr	458.85K	1.31%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 05, 2024	Brockstedt Dirk G.	CHIEF SCIENTIFIC OFFICER	Sell	$20.46K
Dec 21, 2023	HO WILLIAM	Chief Medical Officer	Sell	$54.20K
Nov 28, 2023	HO WILLIAM	Chief Medical Officer	Sell	$20.58K
Oct 03, 2023	HO WILLIAM	Chief Medical Officer	Sell	$39.42K
Aug 18, 2023	HO WILLIAM	Chief Medical Officer	Sell	$47.30K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	1
2023 Q4	-	3
2023 Q3	-	1
2023 Q2	-	1

RAPT Ownership FAQ

Who Owns RAPT Therapeutics?

RAPT Therapeutics shareholders are primarily institutional investors at 82.35%, followed by 1.84% insiders and 15.81% retail investors. The average institutional ownership in RAPT Therapeutics's industry, Biotech Stocks , is 44.85%, which RAPT Therapeutics exceeds.

Who owns the most shares of RAPT Therapeutics?

RAPT Therapeutics’s largest shareholders are Fmr (5.24M shares, 13.55%), Vanguard group (3.11M shares, 8.05%), and Column group (2.68M shares, 6.94%). Together, they hold 28.54% of RAPT Therapeutics’s total shares outstanding.

Does Blackrock own RAPT Therapeutics?

Yes, BlackRock owns 6.32% of RAPT Therapeutics, totaling 2.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.44M$. In the last quarter, BlackRock decreased its holdings by -32.323K shares, a -1.31% change.

Who is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.47% of its assets in 2.68M RAPT Therapeutics shares, valued at 8.18M$.

Who is the top mutual fund holder of RAPT Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of RAPT Therapeutics shares, with 5.77% of its total shares outstanding invested in 2.01M RAPT Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools